Renatus, a pharma company pioneering next generation cyclodextrin-based therapies for the safe treatment of cholesterol-associated diseases, today opened its official website to public.

To keep updated, please follow:

LinkedIn Page: https://www.linkedin.com/company/renatustx/

Twitter Page: https://twitter.com/RENATUS_Inc

About RENATUS

Renatus is a pharma company thriving to develop next generation cyclodextrins to provide safe treatment options for patients living with cholesterol-associated diseases. Renatus seeks to provide critical impact in developing translational cyclodextrin therapies and fulfill its vision to protect the world from various cholesterol-associate diseases. For more information, please visit www.renatustx.com